About
Specialty Pharma
Areas of Focus
Categories
NJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
367
By Phase
PHASE3: 3
By Status
COMPLETED: 3NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05634746Lead Sponsor
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
PHASE3Completed
218 participants
Started: Dec 29, 2022 · Completed: Aug 12, 2024
NCT05083312Lead Sponsor
Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial
PHASE3Completed
6 participants
Started: Sep 30, 2021 · Completed: Sep 5, 2022
NCT04281108Lead Sponsor
Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
PHASE3Completed
143 participants
Started: Jan 30, 2020 · Completed: Oct 24, 2022
NCT05095116Lead Sponsor
Expanded Access Protocol for Patients With Eosinophilic Esophagitis
N/ANO_LONGER_AVAILABLE
Locations (1)
Headquarters
Blue Bell, PA, United States
Map
Loading map...